{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-021967","form_type":"8-K","ticker":"SCNX","cik":"0001382574","company_name":"Scienture Holdings, Inc.","filed_at":"2024-05-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.175531+00:00","generated_at":"2026-06-01T07:21:40.708471+00:00","sec_items":["3.01","5.02","7.01","9.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"TRxADE Health receives Nasdaq non-compliance notice for late Q1 10-Q; directors resign, new ones appointed","bullets":["Received Nasdaq notice on May 23, 2024 for failing to timely file Q1 10-Q; must submit compliance plan by July 22, 2024.","Potential extension to Nov 18, 2024; no immediate effect on listing or trading.","Appointed Mayur Doshi (CEO of AlfaGene Bioscience) and Narasimhan Mani (former CEO of Kesin Pharma) as directors on May 28, 2024.","Directors Jeff Newell and Michael Peterson voluntarily resigned on May 30, 2024; no dispute with the Company.","Resigned directors receive cash compensation through June 30, 2024; unvested shares fully vested on resignation date."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-021967","json":"https://secwatch.observer/filing/0001493152-24-021967.json","markdown":"https://secwatch.observer/filing/0001493152-24-021967.md","text":"https://secwatch.observer/filing/0001493152-24-021967.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1382574/000149315224021967/0001493152-24-021967-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1382574/000149315224021967/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T07:21:40.708471+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5271fc7a3b","claim":"Jeff Newell resigned as Director at Scienture Holdings, Inc..","evidence_excerpt":"On May 30, 2024, Jeff Newell and Michael L. Peterson each voluntarily resigned as a directors of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315224021967/0001493152-24-021967-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"8fe42e9191","claim":"Narasimhan Mani was appointed as Director at Scienture Holdings, Inc..","evidence_excerpt":"On May 28, 2024, the Company’s board of directors (the “Board”) appointed Mayur Doshi and Narasimhan Mani to the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315224021967/0001493152-24-021967-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"abf94e0ba8","claim":"Michael L. Peterson resigned as Director at Scienture Holdings, Inc..","evidence_excerpt":"On May 30, 2024, Jeff Newell and Michael L. Peterson each voluntarily resigned as a directors of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315224021967/0001493152-24-021967-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"c079dcc290","claim":"Mayur Doshi was appointed as Director at Scienture Holdings, Inc..","evidence_excerpt":"On May 28, 2024, the Company’s board of directors (the “Board”) appointed Mayur Doshi and Narasimhan Mani to the Board.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1382574/000149315224021967/0001493152-24-021967-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}